Grants per year
Personal profile
Research Interests
My interests include treating primary brain tumors such as gliomas and meningiomas. I also have a specific interest in metastatic disease to the brain from systemic cancers such as melanoma, lung and breast cancer and lead multiple trials in both primary brain tumors and metastatic disease. I am interested in providing novel care to my patients while maintaining quality of life.
Certifications and Licenses
| Neurology |
Training Experience
| 2008 | Internship, Evanston Hospital |
| 2011 | Residency, Northwestern University, McGaw Medical Center |
| 2012 | Fellowship, Northwestern University, McGaw Medical Center |
Education/Academic qualification
MD, Northeastern Ohio University
… → 2007
Keywords
- Brain Cancer / Nervous System Cancer
- Neuro-Oncology
- Neurology
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 16 Similar Profiles
temozolomide
Medicine & Life Sciences
Glioma
Medicine & Life Sciences
Glioblastoma
Medicine & Life Sciences
Neoplasm Metastasis
Medicine & Life Sciences
Brain Neoplasms
Medicine & Life Sciences
Breast Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Central Nervous System
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2010 2023
DRUG M16-534 - Study Evaluating Ocular Side Effects of Depatux-M (ABT-414)
5/14/19 → 5/14/22
Project: Research project
Prot#17-546: NU DF18C03 - A Phase II Study of Atezolizumab in Combination with Pertuzumab Plus High-Dose Trastuzumab for the Treatment of Central Nervous System Metastases in Patients with Her2-Positive Breast Cancer
Dana Farber Cancer Institute, Genentech, Inc.
3/26/19 → 3/26/22
Project: Research project
SPORE for Translational Approaches to Brain Cancer
Ahmed, A. U., Balyasnikova, I. V., Bartom, E. T., Brat, D. J., Chandler, J. P., Cheng, S., Horbinski, C. M., Hu, B., James, C. D., Kumthekar, P. U., Leikin, R. G., Lesniak, M. S., Liu, B. P., Lukas, R. V., Mirkin, C. A., Platanias, L. C., Sachdev, S., Scholtens, D. M., Stegh, A. H., Stupp, R. & Wainwright, D. A.
8/17/18 → 7/31/23
Project: Research project
Brain Neoplasms
Glioblastoma
Therapeutics
Neoplasms
Survival
Project 3: Using RNAi-based Spherical Nucleic Acid (SNA) Nanoconjugates Targeting Bcl2L12 to Promote Therapy-Induced Apoptosis in Glioblastoma Subproject for Institution # SP0045923
Kumthekar, P. U. & Stegh, A. H.
8/17/18 → 7/31/23
Project: Research project
Nanoconjugates
Glioblastoma
RNA Interference
Nucleic Acids
Brain Neoplasms
Research Output 2013 2019
Comparison of biomarker assays for EGFR: Implications for precision medicine in patients with glioblastoma
Lassman, A. B., Roberts-Rapp, L., Sokolova, I., Song, M., Pestova, E., Kular, R., Mullen, C., Zha, Z., Lu, X., Gomez, E., Bhathena, A., Maag, D., Kumthekar, P. U., Gan, H. K., Scott, A. M., Guseva, M., Holen, K. D., Ansell, P. J. & van den Bent, M. J., Jun 1 2019, In : Clinical Cancer Research. 25, 11, p. 3259-3265 7 p.Research output: Contribution to journal › Article
Open Access
Precision Medicine
Glioblastoma
Fluorescence In Situ Hybridization
RNA Sequence Analysis
Biomarkers
Lifetime occurrence of brain metastases arising from lung, breast, and skin cancers in the elderly: A SEER-Medicare study
Ascha, M. S., Ostrom, Q. T., Wright, J., Kumthekar, P. U., Bordeaux, J. S., Sloan, A. E., Schumacher, F. R., Kruchko, C. & Barnholtz-Sloan, J. S., May 1 2019, In : Cancer Epidemiology Biomarkers and Prevention. 28, 5, p. 917-925 9 p.Research output: Contribution to journal › Article
Skin Neoplasms
Medicare
Lung Neoplasms
Epidemiology
Breast Neoplasms
Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report
Lamano, J. B., Quaggin-Smith, J. A., Horbinski, C. M., Tate, M. C., Grimm, S. A., Kumthekar, P. U. & Bloch, O., Jun 1 2019, In : Journal of Clinical Neuroscience. 64, p. 18-21 4 p.Research output: Contribution to journal › Article
Colitis
Glioblastoma
Cytomegalovirus
temozolomide
Survival
5
Citations
(Scopus)
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR -amplified, recurrent glioblastoma: Results from an international phase I multicenter trial
Lassman, A. B., Van Den Bent, M. J., Gan, H. K., Reardon, D. A., Kumthekar, P. U., Butowski, N., Lwin, Z., Mikkelsen, T., Nabors, L. B., Papadopoulos, K. P., Penas-Prado, M., Simes, J., Wheeler, H., Walbert, T., Scott, A. M., Gomez, E., Lee, H. J., Roberts-Rapp, L., Xiong, H., Ansell, P. J. & 4 others, Jan 1 2019, In : Neuro-oncology. 21, 1, p. 106-114 9 p.Research output: Contribution to journal › Article
temozolomide
Glioblastoma
Epidermal Growth Factor Receptor
Multicenter Studies
Safety
6
Citations
(Scopus)
Differential response of glioma stem cells to arsenic trioxide therapy is regulated by MNK1 and mRNA translation
Bell, J. B., Eckerdt, F., Dhruv, H. D., Finlay, D., Peng, S., Kim, S., Kroczynska, B., Beauchamp, E. M., Alley, K., Clymer, J., Goldman, S., Cheng, S. Y., James, C. D., Nakano, I., Horbinski, C., Mazar, A. P., Vuori, K., Kumthekar, P., Raizer, J., Berens, M. E. & 1 others, Jan 1 2018, In : Molecular Cancer Research. 16, 1, p. 32-46 15 p.Research output: Contribution to journal › Article
MAP Kinase Kinase 1
Protein Biosynthesis
Glioma
Stem Cells
Glioblastoma